|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 275/04 | (2006.01) |
| C07D 417/04 | (2006.01) | ||
| C07D 471/08 | (2006.01) | ||
| C07D 513/04 | (2006.01) | ||
| C07D 487/10 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 239/80 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 403/04 | (2006.01) | ||
| A61K 31/428 | (2006.01) | ||
| A61K 31/429 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/498 | (2006.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3558955 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17832646.8 |
| Date of filing the European patent application | 2017-12-21 | |
| (97) | Date of publication of the European application | 2019-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation | 2021-11-10 |
| (86) | Number | PCT/US2017/067801 |
| Date | 2017-12-21 |
| (87) | Number | WO 2018/119183 |
| Date | 2018-06-28 |
| (30) | Number | Date | Country code |
| 201662438334 P | 2016-12-22 | US |
| (72) |
LANMAN, Brian Alan , US
CEE, Victor J. , US
PICKRELL, Alexander J. , US
REED, Anthony B. , US
YANG, Kevin C. , US
KOPECKY, David John , US
WANG, Hui-Ling , US
LOPEZ, Patricia , US
ASHTON, Kate , US
BOOKER, Shon , US
TEGLEY, Christopher M. , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Benzizotiazolo, izotiazolo[3,4-b]piridazino ir ftalazino, pirido[2,3-d] piridazino ir pirido[2,3-d]pirimidino dariniai, kaip KRAS G12C inhibitoriai, skirti plaučių, kasos arba storosios žarnos vėžio gydymui |
| BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 9 | 208.00 EUR |
| 2026-12-21 |